Hyperkalemia and Oxygen saturation decreased

Summary:

Oxygen saturation decreased is found among people with Hyperkalemia, especially for people who are female, 60+ old.

The study analyzes which people have Oxygen saturation decreased with Hyperkalemia. It is created by eHealthMe based on reports of 31 people who have Hyperkalemia from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Hyperkalemia?

Hyperkalemia (damage to or disease of the kidney) is found to be associated with 1,957 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Hyperkalemia.

What is Oxygen saturation decreased?

Oxygen saturation decreased is found to be associated with 1,859 drugs and 2,092 conditions by eHealthMe. Check the latest studies of Oxygen saturation decreased.



On Jul, 11, 2026

31 people who have Hyperkalemia and Oxygen Saturation Decreased are studied.

Would you have Oxygen saturation decreased when you have Hyperkalemia?

Gender of people who have Hyperkalemia and experienced Oxygen Saturation Decreased *:

  • female: 61.29 %
  • male: 38.71 %

Age of people who have Hyperkalemia and experienced Oxygen Saturation Decreased *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 3.33 %
  • 50-59: 20.0 %
  • 60+: 76.67 %

Common co-existing conditions for these people *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 9.68%
  2. High Blood Pressure: 3 people, 9.68%
  3. Insomnia (sleeplessness): 2 people, 6.45%
  4. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 6.45%
  5. Gastric Ulcer (stomach ulcer): 1 person, 3.23%
  6. Arthritis (form of joint disorder that involves inflammation of one or more joints): 1 person, 3.23%
  7. Cardiac Disorder: 1 person, 3.23%
  8. Cataract (clouding of the lens inside the eye): 1 person, 3.23%
  9. Cerebral Infarction (less blood supply to brain resulting tissue damage): 1 person, 3.23%
  10. Constipation: 1 person, 3.23%

Common drugs taken by these people *:

  1. Veltassa: 25 people, 80.65%
  2. Lantus: 6 people, 19.35%
  3. Novolog: 5 people, 16.13%
  4. Vitamin D2: 4 people, 12.90%
  5. Actos: 4 people, 12.90%
  6. Lasix: 4 people, 12.90%
  7. Plavix: 4 people, 12.90%
  8. Rapamune: 4 people, 12.90%
  9. Relistor: 3 people, 9.68%
  10. Insulin: 3 people, 9.68%

Common symptoms for these people *:

  1. Pneumonia: 10 people, 32.26%
  2. Dyspnea (difficult or laboured breathing): 7 people, 22.58%
  3. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 5 people, 16.13%
  4. Hypotension (abnormally low blood pressure): 5 people, 16.13%
  5. Hospitalisation: 5 people, 16.13%
  6. Nausea And Vomiting: 5 people, 16.13%
  7. Abdominal Discomfort: 4 people, 12.90%
  8. Death: 4 people, 12.90%
  9. Lung Neoplasm Malignant (cancer tumour of lung): 4 people, 12.90%
  10. Impaired Reasoning: 3 people, 9.68%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Oxygen saturation decreased?

- Check whether Oxygen saturation decreased is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Oxygen saturation decreased:

All the conditions that are associated with Oxygen saturation decreased:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Oxygen saturation decreased and Hyperkalemia, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: